<DOC>
	<DOCNO>NCT01369719</DOCNO>
	<brief_summary>Thalassemic patient often suffer iron overload due frequent blood transfusion . Oral iron chelators reduce iron overload transfusion dependent patient . The aim study compare efficacy safety osveral desferal transfusional iron overload patient Î²-Thalassemia intermediate Thalassemia Bandarabbas .</brief_summary>
	<brief_title>Efficacy Safety Desferal Versus Osveral Transfusional Iron Overload</brief_title>
	<detailed_description>This double blind randomize control trial Efficacy safety Osveral Desferal thalassemic patient .</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Deferoxamine</mesh_term>
	<criteria>Confirmed intermedia major thalassemia More 2 year old Serum Ferritin level &gt; 1000 Normal Creatinine Complete Blood Count ( CBC ) HCV , HBV HIV positive patient</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Thalassemia</keyword>
	<keyword>Iron overload</keyword>
	<keyword>transfusion</keyword>
	<keyword>osveral</keyword>
	<keyword>desferal</keyword>
</DOC>